Aclaimant, a Chicago-based risk management software company, today announced the U.S. Patent and Trademark Office (USPTO) has awarded it patent number 12,198,195 for its groundbreaking approach to ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

Researchers have developed a new AI algorithm, called Torque Clustering, that significantly improves how AI systems independently learn and uncover patterns in data, without human guidance.

A NEW study has demonstrated that AI can be used alongside mammography to effectively identify women at high risk of breast ...

Linkedin co-founder Reid Hoffman has launched a startup with the intention of using AI to fuel drug discovery. He is ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Ovarian tumors, often detected incidentally, pose a diagnostic challenge that requires careful management. Decisions depend on assessing the malignancy risk and addressing patient symptoms. For benign ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

Doctors are being warned about using AI software to record clinical notes during patient consultations after dangerous errors ...

BBC Countryfile presenter Julia Bradbury says it delayed her cancer diagnosis. Here's everything you need to know ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...